ABCC7 p.Asp44Gly
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 10923036
[PubMed]
Claustres M et al: "Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France."
No.
Sentence
Comment
108
g D44G, 300delA, W57X, 405+1G>A, D110H, E116K, 541del4, 542del7, L137R, 621+2T>G, I175V, H199R, H199Y, C225X, V232D, Q290X, E292X, G314V, T338I, 1221delCT, W401X, Q452P, I502T, 1716+2T>C, G544S, R560S, A561E, V562I, Y569D, 1898+3A>G, 1898+5G>A, G628R(G>A), 2143delT, G673X, R851X, Q890X, S977F, 3129del4, 3154delG, 3271+1G>A, G1061R, R1066L, R1070W, 3601-17T>C, S1196X, 3732delA, G1249R, 3898insC, 4374+1G>A, del25kb.
X
ABCC7 p.Asp44Gly 10923036:108:2
status: NEW
PMID: 1379210
[PubMed]
Fanen P et al: "Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions."
No.
Sentence
Comment
66
In TABLE 1 Oligonucleotides Used for Amplification and DGGE Analysis of CFTR Gene Exons Annealing Amplified Denaturant Exon PCR primers, 5` + 3 temperature ("C) product (bp) 1 2 3 4 5 6a 6b 7 8 9 10 11 12 13 14a 14b 15 16 17a 17b 18 19 20 21 22 23 24 CGTAGTGGGTGGAGAAAGC (CFl) [55 GC] CCAAAGCCAACCCATACACA (GCCFl) CCAAATCAAGTGAATATCTG (CF2) [40 GC] TAATAATATGAATTTCTCTCTT (GCCFB) TTGGATATACTTGTGTGAAT (CF3) [40 GC] TTCGTAGTCTTTTCATAATC (GCCF3) TGTGTTGAAATTCTCAGGGT (CF4) [40 GC] CAGAATATATGTGCCATGGG (GCCF4) [35GC] TATTTGTATTTTGTTTGTTGA (GCCF5) CTTTCCAGTTGTATAATTTA (CF5) [50 GC] TGGAAGATACAATGACACCTG (GCCFGa) GCATAGAGCAGTCCTGGTTT (CF6a) TATGACTTAAAACCTTGAGC (CFGb) [40 GCIAAGGACAGAATTACTAACAA (GCCFGb) CATCCTGAATTTTATTGTTA (CF7) [50 GC] ATCATAGTATATAATGCAGC (GCCF7) [50 GC] TAAAGTAGATGTAATAATGC (GCCFS) ATTTTATTCGCCATTAGGAT (CFS) TGAAAATATCTGACAAACTC (CF9) GGGGAATTATTTGAGAAAGC (CF9i) [40 GC] CCTTCCAGCACTACAAACTA (GCCFS) TCCTGAGCGTGATTTGATAA (CFlO) [35 GCIATTTGGGTAGTGTGAAGGG (GCCFlO) [35 GC] CAGATTGAGCATACTAAAAGTG (GCCFll) CATTTACAGCAAATGCTTGCTAG (CFll) ATGACCAGGAAATAGAGAGG (CF12) [30 GC] GCTACATTCTGCCATACCAA (GCCF12) [35 GC] TATATCTTAAAGCTGTGTCTGT (GCCF1311) TCCCTGCTCAGAATCTGGTA (CF1312) [50 GC] CCCTTACAAATGAATGGCAT (GCCF1321) TATCCAGTTCAGTCAAGTTT (CF1322) [50 CC] CCCTTACAAATGAATGGCAT (GCCF1321) TACATATTGCATTCTACTCA (CF1323) CAAAATGCTAAAATACGAGACA (CF13-3) TCCCTGCTCAGAATCTGGTA (CF1312) [35 GC] GGTGGCATGAAACTGTACTG (GCCF14a) TGTATACATCCCCAAACTATCT (CF14a) AATAGGTGAAGATGTTAGAA (CF14b) [40 GC] ATAAAACACAATCTACACAA (GCCF14b) TCAGTAAGTAACTTTGGCTGC (CF15) [40 GC] CCTATTGATGGTGGATCAGC (GCCF15) [25 GC] TCTGAATGCGTCTACTGTGA (GCCF16) GCAATAGACAGGACTTCAAC (CF16) [35 GC] TGCAATGTGAAAATGTTTAC (GCCF17a) CTCTTATAGCTTTTTTACAA (CF17a) [40 GC] TTTGTGTTTATGTTATTTGC (GCCFl7b) TGCAGCATTTTATTCATTGA (CF17b) ATCATTTCTATTCTCATTTG (CFl7bi) TAGGAGAAGTGTGAATAAAG (CF18) [40 GC] ATACTTTGTTACTTGTCTGA (GCCF18) GTGAAATTGTCTGCCATTCT (CF19) [45 GC] AGGCTACTGGGATTCACTTA (GCCF19) [35 CC] TATGTCACAGAAGTGATCCC (GCCFZO) TGAGTACAAGTATCAAATAGC (CF20) TGAAATATTTTACAATACAATAAGGG (CF21) [40 CC] GCCATTTGTGTTGGTATGAG (GCCF21) TTTTAGAATGTCAACTGCTT (CF22) [50 GC] ATGATTCTGTTCCCACTGTG (GCCF22) [40 GC] CTGTTCTGTGATATTATGTG (GCCF23) GTTATCAAGAATTACAAGGG (CF23) TTTCTGTCCCTGCTCTGGTC (CF24) [40 GC] TCCCACGAGCTCCAATTCCA (GCCF24) 55 451 range (%) 40-80 50 240 lo-60 50 323 lo-60 55 369 30-80 45 235 lo-60 55 345 50 301 40-90 and lo-60 lo-60 50 365 lo-60 45 302 lo-60 55 375 lo-60 55 298 lo-60 55 336 lo-60 50 224 lo-60 55 296 lo-60 55 516 25-75 50 318 40-90 50 454 lo-60 55 545 O-60 55 276 50 168 lo-60 lo-60 55 390 lo-60 55 323 lo-60 45 283 lo-60 50 382 lo-60 50 266 30-80 48 277 lo-60 55 55 407 302 30-80 lo-60 55 272 55 340 lo-60 and 30-80 30-80 50 242 lo-60 60 362 30-80 Running time (h) 7 3 3 5 3 5 5 4 6 3 5 5 4 3 3 2 4 4 2 6 5 3 5 3 4 4 3 3 5 5 5 5 5 3 4 TABLE 2 Mutations Identified in this Study 773 Name Amino acid change Nucleotide change Exon - D44G 241delAT 574delA G1`78R 711 + 1 G -.
X
ABCC7 p.Asp44Gly 1379210:66:2936
status: NEW89 Analysis of the Remaining Exons Other mutations or candidate mutations were detected outside the regions cited above and included D44G, 241delAT (exon 2) (Fig. l), G178R, 711 + 1 G-T (exon 5), W1063X, R1066C, Y1092X (exon 17b) (Fig. 2), and 4374 + 1 G-A (intron 23).
X
ABCC7 p.Asp44Gly 1379210:89:130
status: NEW